Date | Time | Source | Headline | Symbol | Company |
10/12/2004 | 5:15PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
10/04/2004 | 5:30PM | PR Newswire (US) | Forest Laboratories to Exceed Fiscal 2005 Second and Third Quarter Mean Earnings Per Share Estimates | NYSE:FRX | Forest Road Acquisition Corp |
09/27/2004 | 9:50AM | PR Newswire (US) | Forest Laboratories Appoints Francis Perier as Senior Vice President - Finance and Chief Financial Officer | NYSE:FRX | Forest Road Acquisition Corp |
09/23/2004 | 9:00AM | PR Newswire (US) | Glenmark Pharmaceuticals and Forest Laboratories Announce Collaboration Agreement on PDE4 Inhibitor for Asthma and COPD | NYSE:FRX | Forest Road Acquisition Corp |
09/08/2004 | 3:10PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
09/07/2004 | 6:41PM | PR Newswire (US) | Forest Laboratories Announces Adoption of On-line Registry for Clinical Studies; Attorney General Agrees to Close Inquiry | NYSE:FRX | Forest Road Acquisition Corp |
09/02/2004 | 10:17AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for C, ERTS, COCO, FRX, and SWIR | NYSE:FRX | Forest Road Acquisition Corp |
08/31/2004 | 5:11PM | PR Newswire (US) | Forest Announces That Neramexane Did Not Demonstrate Statistical Significance in Recently Completed Phase III Trial in Patients | NYSE:FRX | Forest Road Acquisition Corp |
08/26/2004 | 9:55AM | PR Newswire (US) | Forest Laboratories Submits Response for Lexapro(R) for Panic Disorder | NYSE:FRX | Forest Road Acquisition Corp |
08/04/2004 | 5:30PM | PR Newswire (US) | ThinkEquity Partners LLC Transitions in Specialty Pharma Research Coverage | NYSE:FRX | Forest Road Acquisition Corp |
07/29/2004 | 8:20PM | PR Newswire (US) | FDA Approves Campral(R) (Acamprosate Calcium) Delayed-Release Tablets for the Treatment of Alcohol Dependence | NYSE:FRX | Forest Road Acquisition Corp |
07/20/2004 | 10:29AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for TASR, DAL, MAT, USB, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
07/20/2004 | 9:02AM | PR Newswire (US) | Forest Laboratories Reports Fiscal First Quarter Earnings of $.60 Per Share | NYSE:FRX | Forest Road Acquisition Corp |
07/20/2004 | 9:02AM | PR Newswire (US) | Forest Laboratories, Inc. Announces Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
07/13/2004 | 12:38PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
07/06/2004 | 9:04AM | PR Newswire (US) | Forest Laboratories, Inc. and PAION GmbH Announce Development and Marketing Agreement for Desmoteplase - Novel Investigational T | NYSE:FRX | Forest Road Acquisition Corp |
06/29/2004 | 5:46PM | PR Newswire (US) | Forest Announces Request for Information From New York State Office of the Attorney General | NYSE:FRX | Forest Road Acquisition Corp |
06/25/2004 | 10:11AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for TXN, RAD, MYL, FRX, and GILD | NYSE:FRX | Forest Road Acquisition Corp |
06/24/2004 | 5:12PM | PR Newswire (US) | Forest Discusses Disclosure of Citalopram Clinical Trial Data in Children and Adolescents | NYSE:FRX | Forest Road Acquisition Corp |
06/24/2004 | 5:11PM | PR Newswire (US) | Forest Announces Results of Recently Completed Lexapro(R) Pediatric Depression Clinical Trial | NYSE:FRX | Forest Road Acquisition Corp |
05/24/2004 | 10:44AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for GE, MVL, FRX, WYE, and ONE | NYSE:FRX | Forest Road Acquisition Corp |
05/06/2004 | 7:39PM | PR Newswire (US) | Depressed Patients Showed Improvement with Lexapro(TM) After Failure with Initial SSRI Treatment | NYSE:FRX | Forest Road Acquisition Corp |
05/06/2004 | 6:21PM | PR Newswire (US) | Namenda(TM) (memantine HCl) Provides Functional and Behavioral Benefits in Patients with Moderate to Severe Alzheimer's Disease | NYSE:FRX | Forest Road Acquisition Corp |
04/28/2004 | 10:07AM | PR Newswire (US) | New Data Highlight Positive Effect of Namenda(TM) on Brain Activity in Patients With Mild to Moderate Alzheimer's Disease | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2004 | 10:41AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for LU, SWIR, AMTD, BSX, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2004 | 9:04AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $0.38 for Fiscal Fourth Quarter | NYSE:FRX | Forest Road Acquisition Corp |
04/16/2004 | 3:52PM | PR Newswire (US) | Forest Laboratories Receives Notification of ANDA Filing For a Generic Equivalent of Lexapro(R) | NYSE:FRX | Forest Road Acquisition Corp |
04/14/2004 | 9:25AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call For Fiscal 2004 Fourth Quarter and Full Year Earnings | NYSE:FRX | Forest Road Acquisition Corp |
03/18/2004 | 4:45PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
03/15/2004 | 4:33PM | PR Newswire (US) | Lexapro(R) as Effective as Paxil(R) and Well Tolerated in the Treatment of Generalized Anxiety Disorder | NYSE:FRX | Forest Road Acquisition Corp |